HPC
TSVT

HM Payson & Co’s 2seventy bio TSVT Stock Holding History

HM Payson & Co’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-400
Closed -$1.57K – 1035
2023
Q3 		$1.57K Buy
400
+200
+100% +$1.31K ﹤0.01% 945
2023
Q2 		$2.02K Hold
200
– – ﹤0.01% 917
2023
Q1 		$2.04K Hold
200
– – ﹤0.01% 918
2022
Q4 		$1.87K Sell
200
-133
-40% -$1.88K ﹤0.01% 860
2022
Q3 		$5K Hold
333
– – ﹤0.01% 860
2022
Q2 		$4K Hold
333
– – ﹤0.01% 916
2022
Q1 		$6K Hold
333
– – ﹤0.01% 895
2021
Q4 		$9K Buy
+333
New +$10.4K ﹤0.01% 885

Other funds holding TSVT

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

HM Payson & Co's TSVT Position: Q4 2023 in Review

HM Payson & Co sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 400 shares — an estimated $1.57K sold.

HM Payson & Co first reported a position in TSVT in Q4 2021 and held it in 8 quarters. The position peaked at $9K in Q4 2021. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • HM Payson & Co reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • HM Payson & Co sold 400 2seventy bio shares in Q4 2023, an estimated $1.57K.
  • HM Payson & Co first reported a position in 2seventy bio in Q4 2021 and held it in 8 quarters.
  • HM Payson & Co's 2seventy bio position peaked at $9K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on HM Payson & Co's 13F filing for Q4 2023, filed 13 Feb 2024.